Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Saved in:
| Title: | Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. |
|---|---|
| Authors: | Collier DA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Lim EY; Department of Medicine, University of Cambridge, Cambridge, UK., Touizer E; Division of Infection and Immunity, University College London, London, UK., Meng B; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Abdullahi A; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK., Elmer A; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Kingston N; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Graves B; NIHR Bioresource, Cambridge, UK., Le Gresley E; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Caputo D; NIHR Bioresource, Cambridge, UK.; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, UK., Cortes-Acevedo P; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico., Barcenas-Morales G; Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico., Linterman MA; Immunology Programme, Babraham Institute, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Davis C; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK., Thomson E; MRC Centre for Virus Research, University of Glasgow, Glasgow, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., McKinney E; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. efm30@medschl.cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. efm30@medschl.cam.ac.uk., Doffinger R; Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. rd270@medschl.cam.ac.uk., Wills M; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. mrw1004@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. mrw1004@cam.ac.uk., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk. |
| Corporate Authors: | CITIID-NIHR BioResource COVID-19 Collaboration |
| Source: | Nature [Nature] 2021 Aug; Vol. 596 (7872), pp. 417-422. Date of Electronic Publication: 2021 Jun 30. |
| Publication Type: | Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
